Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of plasma efavirenz exposure in HIV‐infected adults and children in South Africa

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 1, 2015-07 ,pp. : 146-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam

By Cuong Do Duy   Thorson Anna   Sönnerborg Anders   Hoa Nguyen Phuong   Chuc Nguyen Thi Kim   Phuc Ho Dang   Larsson Mattias  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 3, 2012-03 ,pp. : 201-208

Informa Healthcare

Access to resources Recommend Favorite

Genotyping of CYP2B6 and therapeutic drug monitoring in an HIV-infected patient with high efavirenz plasma concentrations and severe CNS side-effects

By Mathiesen Sofie   Stenz Justesen Ulrik   Von Lüttichau Hans-Rudolf   Eg Hansen Ann-Brit  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 8, 2006-08 ,pp. : 733-735

Informa Healthcare

Access to resources Recommend Favorite

Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients

By Di Biagio Antonio  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 587-590

Springer Publishing Company

Access to resources Recommend Favorite